125 related articles for article (PubMed ID: 12039913)
1. In vitro studies of core peptide-bearing immunopotentiating reconstituted influenza virosomes as a non-live prototype vaccine against hepatitis C virus.
Hunziker IP; Grabscheid B; Zurbriggen R; Glück R; Pichler WJ; Cerny A
Int Immunol; 2002 Jun; 14(6):615-26. PubMed ID: 12039913
[TBL] [Abstract][Full Text] [Related]
2. Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells.
Amacker M; Engler O; Kammer AR; Vadrucci S; Oberholzer D; Cerny A; Zurbriggen R
Int Immunol; 2005 Jun; 17(6):695-704. PubMed ID: 15843436
[TBL] [Abstract][Full Text] [Related]
3. Perspectives: towards a peptide-based vaccine against hepatitis C virus.
Hunziker IP; Zurbriggen R; Glueck R; Engler OB; Reichen J; Dai WJ; Pichler WJ; Cerny A
Mol Immunol; 2001 Dec; 38(6):475-84. PubMed ID: 11741697
[TBL] [Abstract][Full Text] [Related]
4. Helper T cell determinant peptide contributes to induction of cellular immune responses by peptide vaccines against hepatitis C virus.
Hiranuma K; Tamaki S; Nishimura Y; Kusuki S; Isogawa M; Kim G; Kaito M; Kuribayashi K; Adachi Y; Yasutomi Y
J Gen Virol; 1999 Jan; 80 ( Pt 1)():187-193. PubMed ID: 9934701
[TBL] [Abstract][Full Text] [Related]
5. Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination.
Vidalin O; Tanaka E; Spengler U; Trépo C; Inchauspé G
DNA Cell Biol; 1999 Aug; 18(8):611-21. PubMed ID: 10463057
[TBL] [Abstract][Full Text] [Related]
6. Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity.
Bungener L; Huckriede A; de Mare A; de Vries-Idema J; Wilschut J; Daemen T
Vaccine; 2005 Jan; 23(10):1232-41. PubMed ID: 15652665
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
Cerny A; McHutchison JG; Pasquinelli C; Brown ME; Brothers MA; Grabscheid B; Fowler P; Houghton M; Chisari FV
J Clin Invest; 1995 Feb; 95(2):521-30. PubMed ID: 7860734
[TBL] [Abstract][Full Text] [Related]
8. Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation.
Schumacher R; Adamina M; Zurbriggen R; Bolli M; Padovan E; Zajac P; Heberer M; Spagnoli GC
Vaccine; 2004 Jan; 22(5-6):714-23. PubMed ID: 14741164
[TBL] [Abstract][Full Text] [Related]
9. Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines.
Shirai M; Chen M; Arichi T; Masaki T; Nishioka M; Newman M; Nakazawa T; Feinstone SM; Berzofsky JA
J Infect Dis; 1996 Jan; 173(1):24-31. PubMed ID: 8537666
[TBL] [Abstract][Full Text] [Related]
10. Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine.
Polakos NK; Drane D; Cox J; Ng P; Selby MJ; Chien D; O'Hagan DT; Houghton M; Paliard X
J Immunol; 2001 Mar; 166(5):3589-98. PubMed ID: 11207320
[TBL] [Abstract][Full Text] [Related]
11. Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan-A/MART-1(26-35) peptide encapsulated into virosomes in vitro.
Schumacher R; Amacker M; Neuhaus D; Rosenthal R; Groeper C; Heberer M; Spagnoli GC; Zurbriggen R; Adamina M
Vaccine; 2005 Dec; 23(48-49):5572-82. PubMed ID: 16165256
[TBL] [Abstract][Full Text] [Related]
12. Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens.
Urbani S; Uggeri J; Matsuura Y; Miyamura T; Penna A; Boni C; Ferrari C
Hepatology; 2001 Jun; 33(6):1533-43. PubMed ID: 11391544
[TBL] [Abstract][Full Text] [Related]
13. Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes.
Arkema A; Huckriede A; Schoen P; Wilschut J; Daemen T
Vaccine; 2000 Jan; 18(14):1327-33. PubMed ID: 10618529
[TBL] [Abstract][Full Text] [Related]
14. Characterization of TAP-independent and brefeldin A-resistant presentation of Sendai virus antigen to CD8+ cytotoxic T lymphocytes.
Zhou X; Liu T; Franksson L; Lederer E; Ljunggren HG; Jondal M
Scand J Immunol; 1995 Jul; 42(1):66-75. PubMed ID: 7631147
[TBL] [Abstract][Full Text] [Related]
15. Effective induction of type 1 cytotoxic T cell responses in mice with DNA vaccine encoding two hepatitis C virus cytotoxic T lymphocyte epitopes.
Shi L; Liu S; Fan GX; Sheng L; Ren HX; Yuan YK
Viral Immunol; 2006; 19(4):702-11. PubMed ID: 17201665
[TBL] [Abstract][Full Text] [Related]
16. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein.
Moriya O; Matsui M; Osorio M; Miyazawa H; Rice CM; Feinstone SM; Leppla SH; Keith JM; Akatsuka T
Vaccine; 2001 Dec; 20(5-6):789-96. PubMed ID: 11738742
[TBL] [Abstract][Full Text] [Related]
17. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by an intrahepatic inoculation with an expression plasmid.
Kamei A; Tamaki S; Taniyama H; Takamura S; Nishimura Y; Kagawa Y; Uno-Furuta S; Kaito M; Kim G; Toda M; Matsuura Y; Miyamura T; Adachi Y; Yasutomi Y
Virology; 2000 Jul; 273(1):120-6. PubMed ID: 10891414
[TBL] [Abstract][Full Text] [Related]
18. Identification of the epitopes on HCV core protein recognized by HLA-A2 restricted cytotoxic T lymphocytes.
Zhou HC; Xu DZ; Wang XP; Zhang JX; Huang Y; Yan YP; Zhu Y; Jin BQ
World J Gastroenterol; 2001 Aug; 7(4):583-6. PubMed ID: 11819836
[TBL] [Abstract][Full Text] [Related]
19. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
[TBL] [Abstract][Full Text] [Related]
20. Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells.
Zweerink HJ; Gammon MC; Utz U; Sauma SY; Harrer T; Hawkins JC; Johnson RP; Sirotina A; Hermes JD; Walker BD
J Immunol; 1993 Mar; 150(5):1763-71. PubMed ID: 7679694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
